From: The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer
RNA Type | Molecules | Origin | Potential functions | Refs. |
---|---|---|---|---|
miRNA | miRNA‑21 | Peripheral blood | Early diagnosis/tumor stage/survival evaluation | |
miRNA-210 | Peripheral blood | Early diagnosis/tumor stage | [116] | |
miRNA-10b | Peripheral blood | Early diagnosis | ||
miRNA-1246 | Peripheral blood | Early diagnosis | [121] | |
miRNA-451a | Peripheral blood | Tumor stage/survival evaluation | [122] | |
miRNA-222 | Peripheral blood | Tumor stage/survival evaluation | [61] | |
miRNA-4525 | Portal vein blood | Recurrence prediction/survival evaluation | [124] | |
miRNA-451a | Portal vein blood | Recurrence prediction/survival evaluation | [124] | |
miRNA-21 | Portal vein blood | Recurrence prediction/survival evaluation | [124] | |
miRNA-21 | Pancreatic juice | Early diagnosis | [125] | |
miRNA-155 | Pancreatic juice | Early diagnosis | [125] | |
miRNA-1246 | Salivary | Early diagnosis | [126] | |
miRNA-4644 | Salivary | Early diagnosis | [126] | |
lncRNA | Sox2ot | Peripheral blood | Tumor stage/survival evaluation | [77] |
HULC | Peripheral blood | Early diagnosis | [75] | |
CRNDE | Peripheral blood | Early diagnosis | [136] | |
MALAT-1 | Peripheral blood | Early diagnosis | [136] | |
circRNA | PDE8A | Peripheral blood | Tumor stage/survival evaluation | [78] |
IARS | Peripheral blood | Tumor stage/survival evaluation | [79] | |
mRNA | WASF2 | Peripheral blood | Early diagnosis/tumor stage/ | [139] |
GPC1 | Peripheral blood | Early diagnosis/tumor stage/ | [140] |